The new coronal antibody developed by Chinese Academy of Sciences has entered phase II clinical trial in the United States

category:Finance
 The new coronal antibody developed by Chinese Academy of Sciences has entered phase II clinical trial in the United States


[the new coronal antibody developed by Chinese Academy of Sciences has entered phase II clinical trial in the United States] according to the latest news from the Institute of Microbiology, Chinese Academy of Sciences, the js016 antibody product developed by the Institute has started clinical trial in China and the United States in June this year, and the clinical trial in the United States has entered phase II.